EFFECT OF FARGALS-CONTAININH SUPERSORBICID IN THE COMPLEX TREATMENT ON MAXILLO - FACIAH OSTEOMIELIT

Authors

  • H.Y.Eshbadalov, N.H.Pulatov, Z.H.Makhkamov Andijan State Medical Institute, Department of Maxillofacial Surgery

DOI:

https://doi.org/10.55640/

Keywords:

maxillofacial region, osteomyelitis, immunology, necrosis, microflora.

Abstract

For complex treatment of 90 patients osteomielit for the first time we have used drug FarGALS developed by specialists of research-manufactoring. Clinico-laboratory and bacteriological evaluations of their effi cacy showed that during use of these preparations FarGALS in the complex treatment of abscess was noted more quick liquidation of local and general signs of inflammation, acceleration of wound cleaning from necrotic mass that led to intensifica tion of wound healing by secondary intention.

Downloads

Download data is not yet available.

References

1.Klimko N., Khostelidi S., Shadrivova O., Volkova A., Popova M., Uspenskaya O., et al. Contrasts between mucormycosis and aspergillosis in oncohematological patients. Med Mycol. 2019;57(Suppl. 2):S138-S144. DOI: 10.1093/mmy/myy116

2.Klimko N.N., Khostelidi S.N., Shadrivova O.V., Bogomolova T.S., Avdeenko Y.L., Volkova A.G., et al. Mucormycosis in oncohematology patients (results of the prospective study). Oncohematology. 2017;12(2):14-22. Russian. (Климко Н.Н., Хостелиди С.Н., Шадривова О.В., Богомолова Т.С., Авдеенко Ю.Л., Волкова А.Г. и соавт. Инвазивный мукормикоз у онкогематологических больных (результаты проспективного исследования). Онкогематология. 2017;12(2):14-22.) DOI: 10.17650/1818-8346-2017-12-2-14-22

3.Rudramurthy S.M., Hoenigl M., Meis J.F., Cornely O.A., Muthu V., Gangneux J.P., et al. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low-and middle-income countries. Mycoses. 2021;64(9):1028-1037. DOI: 10.1111/myc.13335

4.Selarka L., Sharma S., Saini D., Sharma S., Batra A., Waghmare V.T., et al. Mucormycosis and COVID-19: an epidemic within a pandemic in India. Mycoses. 2021;64(10):1253-1260. DOI: 10.1111/myc.13353

5.Singh A.K., Singh R., Joshi S.R., Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146. DOI: 10.1016/j.dsx.2021.05.019

Downloads

Published

2026-04-02

How to Cite

EFFECT OF FARGALS-CONTAININH SUPERSORBICID IN THE COMPLEX TREATMENT ON MAXILLO - FACIAH OSTEOMIELIT. (2026). Journal of Multidisciplinary Sciences and Innovations, 5(4), 176-179. https://doi.org/10.55640/

Similar Articles

1-10 of 333

You may also start an advanced similarity search for this article.